← Patent-cliff monitor small molecule VYKAT XR DIAZOXIDE CHOLINE
Loss of exclusivity November 2035 latest FDA-listed patent expiry
Drug detail Brand name VYKAT XR Active ingredient DIAZOXIDE CHOLINE Strength 150MG Dosage form TABLET, EXTENDED RELEASE Route ORAL Modality Small molecule FDA approval March 2025 Marketing status RX
Listed patents Patent Expires Type 12343348 November 2035 use U-4211 12178823 November 2035 use U-4167 9757384 November 2035 use U-4167 12419895 November 2035 use U-4275 7799777 March 2029 substance 7572789 December 2026 substance, product
Regulatory exclusivity Code Expires ODE-532 May 2032 ODE-532 March 2032 NP March 2028
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.